We are live on ! Find out more
AAF

Andra AP-fonden Portfolio holdings

AUM $8.39B
1-Year Est. Return 21.19%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
10 Year Est. Return
AUM
$5.95B
AUM Growth
+$319M
Cap. Flow
+$251M
Cap. Flow %
4.22%
Top 10 Hldgs %
16.32%
Holding
451
New
88
Increased
179
Reduced
148
Closed
36

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$55.3M
2
AVGO icon
Broadcom
AVGO
+$42.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$29.8M
4
MSFT icon
Microsoft
MSFT
+$27M
5
HD icon
Home Depot
HD
+$26.7M

Sector Composition

Rank Sector Weight
1 Technology 32.56%
2 Healthcare 14.4%
3 Consumer Discretionary 10.02%
4 Financials 9.97%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.61T
$215M 3.61%
1,737,600
+193,600
+13% +$19.6M
AAPL icon
2
Apple
AAPL
$4.97T
$162M 2.72%
769,800
-58,300
-7% -$10.9M
QCOM icon
3
Qualcomm
QCOM
$165B
$115M 1.93%
577,400
+41,800
+8% +$7.9M
META icon
4
Meta Platforms (Facebook)
META
$1.48T
$89.4M 1.5%
177,400
+54,800
+45% +$26.6M
MSFT icon
5
Microsoft
MSFT
$2.91T
$82.2M 1.38%
183,900
-64,000
-26% -$27M
JNJ icon
6
Johnson & Johnson
JNJ
$640B
$67.4M 1.13%
461,200
+272,200
+144% +$40.5M
NTAP icon
7
NetApp
NTAP
$33.9B
$64.3M 1.08%
499,200
-35,800
-7% -$4.02M
AMAT icon
8
Applied Materials
AMAT
$350B
$64.2M 1.08%
272,200
-30,300
-10% -$6.5M
LLY icon
9
Eli Lilly
LLY
$1.08T
$57.3M 0.96%
63,300
+21,900
+53% +$17.5M
JPM icon
10
JPMorgan Chase
JPM
$919B
$54.6M 0.92%
270,000
+121,800
+82% +$23.8M
KLAC icon
11
KLA
KLAC
$224B
$54.2M 0.91%
657,000
+90,000
+16% +$6.65M
NFLX icon
12
Netflix
NFLX
$306B
$52.6M 0.88%
780,000
-179,000
-19% -$11.2M
ADBE icon
13
Adobe
ADBE
$105B
$51.2M 0.86%
92,100
-39,500
-30% -$19.1M
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.11T
$48.1M 0.81%
264,337
-139,969
-35% -$23.6M
HPQ icon
15
HP
HPQ
$26B
$45.8M 0.77%
1,308,000
-422,700
-24% -$13.4M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$73B
$45.6M 0.77%
43,400
+16,900
+64% +$16.4M
DKS icon
17
Dick's Sporting Goods
DKS
$18.5B
$43.9M 0.74%
204,100
-2,500
-1% -$521K
CTSH icon
18
Cognizant
CTSH
$26.5B
$43.5M 0.73%
639,997
-170,700
-21% -$11.6M
IT icon
19
Gartner
IT
$11.1B
$43.3M 0.73%
96,400
+1,200
+1% +$534K
GOOG icon
20
Alphabet (Google) Class C
GOOG
$4.11T
$41.7M 0.7%
227,400
-175,100
-44% -$29.8M
KMB icon
21
Kimberly-Clark
KMB
$37.5B
$41.6M 0.7%
301,200
+21,700
+8% +$2.9M
CL icon
22
Colgate-Palmolive
CL
$75B
$40.9M 0.69%
421,085
+71,100
+20% +$6.56M
ULTA icon
23
Ulta Beauty
ULTA
$21.9B
$40.4M 0.68%
104,600
+27,900
+36% +$11.3M
ABBV icon
24
AbbVie
ABBV
$466B
$39.6M 0.66%
230,700
-51,000
-18% -$8.45M
INTU icon
25
Intuit
INTU
$91.3B
$38.2M 0.64%
58,200
-5,700
-9% -$3.54M

Similar funds

Andra AP-fonden's Q2 2024 Portfolio in Review

As of Q2 2024, Andra AP-fonden held 451 positions worth $5.95B, up 5.7% from $5.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Andra AP-fonden deployed $251M of net new capital in Q2 2024, opening 88 new positions and adding to 179 existing holdings. Its largest new stake was Accenture: 115,208 shares worth $35M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $42.3M trimmed.

  • Andra AP-fonden's largest Q2 2024 buy was Accenture: 115,208 shares worth $35M.
  • Andra AP-fonden added most to Johnson & Johnson in Q2 2024, an estimated $40.5M increase.
  • Andra AP-fonden's biggest Q2 2024 reduction was Broadcom, cutting an estimated $42.3M.
  • Andra AP-fonden fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $55.3M.
  • Andra AP-fonden's ten largest holdings make up 16% of its $5.95B portfolio in Q2 2024.
  • Andra AP-fonden opened 88 new positions and closed 36 in Q2 2024.
  • Andra AP-fonden's portfolio value rose 5.7% quarter-over-quarter to $5.95B.

Based on Andra AP-fonden's 13F filing for Q2 2024, filed 7 Aug 2024.